Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

Jean H. Sewell Joins Shore Bank (HMPR) as Senior Vice President – Director of Marketing

Posted on January 9, 2013 by MissionIR

Yesterday, the Bank of Hamption Roads’ (“BHR”) holding company, Hampton Roads Bankshares, Inc. (Nasdaq: HMPR), announced that Jean H. Sewell has joined its Shore Bank entity as Senior Vice President – Director of Marketing. Ms. Sewell will report to Shore … Continue reading →

Posted in Small Cap News | Leave a comment

Medbox Inc. (MDBX) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Medbox, through its subsidiary Prescription Vending Machines Inc., engages in developing a patented machine that dispenses medication to individuals based on biometric identification. The company’s flagship product is MedBox, an automated medicine dispensing machine that utilizes biometrics to identify users … Continue reading →

Posted in EBD Group Conference | Leave a comment

Aethlon Medical Inc. (AEMD) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Aethlon Medical is a development stage medical device company focused on creating devices for the treatment of cancer, infectious diseases and other life-threatening conditions. The company’s Aethlon Hemopurifier is intended for the treatment of cancer, hepatitis-C virus, human immunodeficiency virus … Continue reading →

Posted in EBD Group Conference | Leave a comment

Amorcyte, a NeoStem company (NBS) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Amorcyte is a biopharm company engaged in the development of proprietary cellular therapies in cardiovascular disease, immunology and regenerative medicine primarily in the United States. Its lead product candidate, AMR-001, which is for the prevention of major adverse cardiac events … Continue reading →

Posted in EBD Group Conference | Leave a comment

Atossa Genetics, Inc. (ATOS) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

Atossa Genetics, known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to eight years before mammography. The … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Athersys Inc. (ATHX) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Athersys is a clinical stage biopharm company growing a pipeline of highly differentiated therapeutics to treat significant and life-threatening diseases. The company’s current product development portfolio consists of MultiStem®, a proprietary stem cell product for the treatment of multiple disease … Continue reading →

Posted in EBD Group Conference | Leave a comment

OncoSec Medical Inc. (ONCS) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

OncoSec Medical is a biotech company focused on the development of treatments addressing advanced-stage skin cancer, specifically: melanoma, Merkel cell lymphoma and cutaneous T-cell lymphoma. ONCS’ proprietary technology, OncoSec Medical System™ (OMS), is based on electroporation and in pre-clinical and … Continue reading →

Posted in EBD Group Conference | Leave a comment

Neuralstem Inc. (CUR) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Neuralstem, a development-stage company focused on the development and commercialization of treatments for central nervous system disease, has developed and maintains a portfolio of patents and patent applications that form base for its research and development efforts in the area … Continue reading →

Posted in EBD Group Conference | Leave a comment

Targeted Medical Pharma, Inc. (TRGM) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

Targeted Medical Pharma is a specialty pharmaceutical company engaged in developing and distributing prescription medical foods to physicians and pharmacies in the U.S. and the Middle East. The company manufactures 10 proprietary prescription-only medical foods and 48 convenience packed kits … Continue reading →

Posted in OneMedForum Conference | Leave a comment

ProMetic Life Sciences (PFSCF) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

ProMetic Life Sciences operates through a group of subsidiaries to specialize in the design of small molecules that mimic unique and specific interactions between proteins. The company’s technologies are applicable to large-scale drug purification, drug development, proteomics and the elimination … Continue reading →

Posted in EBD Group Conference | Leave a comment